The doctor spoke about the advantages of theranostics in the treatment of cancer

Theranostics provides stable remission in 30% of patients and a positive response to treatment in 60% of cases. This was announced on July 16 by Nidal Salim, Director of the Institute of Oncology at the European Medical Center (EMC).

He explained that theranostics is a field of medicine that combines molecular diagnostics with targeted cancer therapy. This approach allows for personalized treatment: using positron emission tomography (PET), computed tomography (CT) and radiopharmaceuticals, doctors can identify specific "targets" in the patient's body and affect pathological cells.

"At the moment, the technique is used to treat neuroendocrine tumors and prostate cancer," Salim said.

"Treatment is as inconspicuous as possible for children": who helps young cancer patients

And what problems do their families face during this multi-year process?

On July 10, Medsi oncologist Valentina Shamrikova noted that no one is immune from developing cancer, but the risk of the disease can be reduced by 20%. According to her, quitting smoking and alcohol, limiting the consumption of red meat, avoiding tanning beds and using products with SPF help reduce the likelihood of the disease. Shamrikova also recommended regular screenings as a preventive measure.